HEARTLAND ADVISORS INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
HEARTLAND ADVISORS INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$4,233,000
-23.8%
200,000
-46.7%
0.30%
-37.6%
Q3 2020$5,558,000
+0.8%
375,0000.0%0.48%
-1.4%
Q2 2020$5,516,000
+25.3%
375,0000.0%0.49%
+4.5%
Q1 2020$4,403,000
-42.4%
375,000
+15.4%
0.47%
-16.5%
Q4 2019$7,638,000
+3.2%
325,000
-18.8%
0.56%
-0.4%
Q3 2019$7,400,000
-0.5%
400,0000.0%0.56%
+3.3%
Q2 2019$7,436,000400,0000.55%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders